These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 17848636)
1. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs. Cozma I; Zhang L; Uddin J; Lane C; Rees A; Ludgate M Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1630-5. PubMed ID: 17848636 [TBL] [Abstract][Full Text] [Related]
2. [Somatostatin receptor genes expression and effects of octreotide on orbital fibroblasts from Graves' ophthalmopathy]. Pasquali D; Notaro A; Esposito D; Vassallo P; Bonavolontà G; Bellastella A; Sinisi AA Minerva Endocrinol; 2001 Sep; 26(3):175-9. PubMed ID: 11753241 [TBL] [Abstract][Full Text] [Related]
3. Short- and long-term effects of octreotide and SOM230 on GH, IGF-I, ACTH, corticosterone and ghrelin in rats. Schmid HA; Silva AP J Endocrinol Invest; 2005; 28(11 Suppl International):28-35. PubMed ID: 16625842 [TBL] [Abstract][Full Text] [Related]
4. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects. Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy. Jyonouchi SC; Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS Thyroid; 2001 Oct; 11(10):929-34. PubMed ID: 11716039 [TBL] [Abstract][Full Text] [Related]
15. Adipogenesis in thyroid eye disease. Crisp M; Starkey KJ; Lane C; Ham J; Ludgate M Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3249-55. PubMed ID: 11006210 [TBL] [Abstract][Full Text] [Related]
16. [Detection, localization and modulation of hyaluronic acid/CD44 receptor expression in patients with endocrine orbitopathy]. Heufelder AE; Bahn RS; Boergen KP; Scriba PC Med Klin (Munich); 1993 Apr; 88(4):181-4, 277. PubMed ID: 8492772 [TBL] [Abstract][Full Text] [Related]
17. Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Zhang L; Baker G; Janus D; Paddon CA; Fuhrer D; Ludgate M Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5197-203. PubMed ID: 17122103 [TBL] [Abstract][Full Text] [Related]
18. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. Kumar S; Nadeem S; Stan MN; Coenen M; Bahn RS J Mol Endocrinol; 2011 Jun; 46(3):155-63. PubMed ID: 21321093 [TBL] [Abstract][Full Text] [Related]
19. Oxidative Stress and Upregulation of Antioxidant Proteins, Including Adiponectin, in Extraocular Muscular Cells, Orbital Adipocytes, and Thyrocytes in Graves' Disease Associated with Orbitopathy. Marique L; Senou M; Craps J; Delaigle A; Van Regemorter E; Wérion A; Van Regemorter V; Mourad M; Nyssen-Behets C; Lengelé B; Baldeschi L; Boschi A; Brichard S; Daumerie C; Many MC Thyroid; 2015 Sep; 25(9):1033-42. PubMed ID: 26176182 [TBL] [Abstract][Full Text] [Related]
20. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy. Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]